INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

830 studies · page 16 of 35

2016 / Review

Western diets and modern lifestyles are linked to a depletion of the human gut microbiome, which is implicated in chronic disease increases.

This article discusses evidence indicating that modern lifestyles, particularly Western diets, have led to a substantial depletion of the human gut microbiome. This microbiome loss is implicated in the widespread increase of chronic diseases. The authors argue this provides an incentive to fundamentally transform human nutrition to be more holistic and microbiome-focused.

Deehan EC, Walter J Trends Endocrinol Metab, 2016. PMID 27079516

2016 / Literature review

A review indicates that dietary fat and fatty foods may exacerbate functional dyspepsia symptoms.

Researchers reviewed 19 relevant papers published between 1992 and 2012 investigating dietary fat intake and functional dyspepsia. Laboratory studies demonstrated that adding fat to a meal led to increased symptoms of fullness, bloating, and nausea in dyspeptic patients. Small intestinal infusions of fat exacerbated gastric hypersensitivity to postprandial distension, and lipids (unlike glucose) heightened perception of distension. Furthermore, long-chain triglycerides appeared more potent than medium-chain triglycerides in triggering fullness, nausea, and hunger suppression.

Khodarahmi M, Azadbakht L Adv Biomed Res, 2016. PMID 27195249

2016 / Narrative review

Recurrent aphthous stomatitis can manifest as a mucosal symptom of gastrointestinal conditions like gluten-sensitive enteropathy.

Recurrent aphthous stomatitis (RAS) is the most common acute oral ulcerative condition in North America and is categorized into simple and complex aphthosis. Lesions of RAS can represent mucosal manifestations of gastrointestinal conditions, including gluten-sensitive enteropathy, ulcerative colitis, and Crohn disease. Successful management depends on accurate diagnosis, classification, identification of provocative factors, and uncovering associated diseases.

Cui RZ, Bruce AJ, Rogers RS Clin Dermatol, 2016. PMID 27343962

2016 / Narrative review

Evidence suggests the gut microbiota acts as a mediator of dietary impact on host metabolic status and obesity.

This review discusses the role of diet and the gut microbiota in metabolic diseases such as obesity and type 2 diabetes. Findings from animal models and human studies indicate that the gut microbiota mediates dietary impacts on host metabolism. Current research is focusing on establishing causal relationships in humans and developing therapeutic interventions like personalized nutrition.

Sonnenburg JL, Bäckhed F Nature, 2016. PMID 27383980

2016 / Document analysis of clinical study reports, protocols, and publications

Analysis of orlistat trials found that published papers reported only 3% to 33% of investigator-reported adverse events due to post hoc filters.

Researchers analyzed 8,716 pages of clinical study reports (CSRs) and protocols from seven randomized placebo-controlled trials of orlistat (4,225 participants) and compared them with published papers. Only 3% to 33% of investigator-reported adverse events appeared in publications due to post hoc filters, despite six of seven papers claiming all adverse events were recorded. In one trial, orlistat-treated participants experienced significantly more days with adverse events than placebo (22.7 d vs. 14.9 d, p < 0.0001) and more severe events, details omitted from CSRs and publications. A key limitation is that the analysis was restricted to one drug tested in the mid-1990s, which may not apply to newer drugs.

Schroll JB, Penninga EI, Gøtzsche PC PLoS Med, 2016. PMID 27529343

2016 / Narrative review

Disturbances in sleep and circadian rhythms are linked to increased risk of weight gain and altered food choices.

This review summarizes recent findings linking sleep and circadian rhythm disturbances to an increased risk of obesity. Sleep and circadian disruptions adversely affect food choices, hunger, appetite, and energy balance, and are associated with lifelong metabolic consequences when occurring in childhood or early adulthood. Upregulation of the endocannabinoid system, altered temporal distribution of caloric intake, and changes in the gut microbiome were identified as potential mechanisms linking sleep loss and circadian misalignment to obesity. Manipulations of the timing of food intake are suggested as potential preventive countermeasures.

Shows an association, not proof of cause and effect.

Broussard JL, Van Cauter E Curr Opin Endocrinol Diabetes Obes, 2016. PMID 27584008

2016 / Comprehensive literature review

A review outlines how enteric ecosystem disruptions may impact metabolic, immune, and brain development in autism spectrum disorder.

This comprehensive literature review examined evidence on enteric ecosystem alterations in Autism Spectrum Disorders (ASDs), including reduced microbiome diversity and macrobiome changes. Factors like dietary habit changes, antibiotic overuse, and reduced exposure to symbiotic organisms are proposed to alter metabolic and immune function and epigenetic regulation during critical developmental windows. The authors discuss theoretical models and preclinical/clinical studies linking these disruptions to the ASD phenotype, noting that valid models could inform future interventions.

Slattery J, MacFabe DF, Kahler SG, et al. Curr Pharm Des, 2016. PMID 27592717

2016 / Narrative review

A plant-based, minimally processed high-fiber diet may rapidly reverse meat-based diet effects on the gut microbiome, though individual responses vary.

This review discusses the relationship between diet, the gut microbiome, and chronic diseases. The diversity of gut microbial species is diminished in nearly all modern chronic conditions studied, with the 'Western diet' thought to drive these conditions through gut dysbiosis. Recent dietary interventions suggest that adopting a plant-based, minimally processed high-fiber diet may rapidly reverse the effects of meat-based diets on the microbiome. However, individual responses to diet can be complicated by host genetics and baseline variations in the gut microbiome.

Pallister T, Spector TD J R Soc Med, 2016. PMID 27609798

2016 / Scientific review

Sugar alcohols can cause gastrointestinal disturbances, though xylitol is better tolerated than hexitols and erythritol typically avoids these reactions.

This review examines gastrointestinal disturbances linked to the consumption of sugar alcohols, with a focus on xylitol. Ingesting pentitol-, hexitol-, and disaccharide-type polyols can trigger gastrointestinal symptoms, particularly in unaccustomed individuals, though adaptation may occur via enzyme induction in intestinal flora. Research indicates that polyol-related osmotic diarrhea presents no intestinal mucosal pathology under normal conditions. Among these, xylitol is better tolerated than hexitols or disaccharide polyols, while erythritol generally avoids gastrointestinal reactions due to its smaller molecular weight and distinct configuration.

Mäkinen KK Int J Dent, 2016. PMID 27840639

2016 / Narrative review

A review outlines evidence connecting nutritional status, gut microbiota composition, and symptoms in children with autism spectrum disorder.

This review examines the current evidence regarding the gut environment and nutritional status of children with autism spectrum disorder (ASD). It highlights that several studies report abnormalities in microbiota composition, differences in microbial metabolites, gastrointestinal discomfort, and food selectivity or picky eating patterns in children with ASD. Potential mechanisms connecting nutrition, gut microbiota, and ASD symptoms via immune, hormonal, or neuronal pathways of the microbiota-gut-brain axis are discussed. The authors note that future studies examining the microbiota alongside dietary intake are needed to inform potential dietary, probiotic, or prebiotic strategies.

Berding K, Donovan SM Nutr Rev, 2016. PMID 27864534

2015 / Narrative review

Dietary interventions and dietary components can modify the composition and metabolic products of the human gut microbiota.

This review summarizes the effects of diet, particularly dietary interventions, on the human gut microbiota. Controlled dietary shifts, including high-protein diets, high-fat diets, prebiotics, probiotics, and polyphenols, alter selected bacterial groups. Additionally, the type and quantity of non-digestible carbohydrates influence faecal bacterial populations and metabolic products formed in the lower gastrointestinal tract. Methodological and intrinsic human confounding factors regarding gut microbiota analyses are also discussed.

Maukonen J, Saarela M Proc Nutr Soc, 2015. PMID 25156389

2015 / Narrative review

Evidence suggests vitamin D may modify immune responses in IBD, with emerging trial data hinting at longer remission periods.

This review evaluates scientific evidence regarding vitamin D and inflammation, focusing primarily on inflammatory bowel disease (IBD). Suboptimal vitamin D status is common in IBD, and some studies suggest it associates with more severe disease. Early data from randomized controlled trials suggest that people with IBD may remain in remission longer when treated with oral vitamin D, though large, well-designed clinical trials are still needed.

O'Sullivan M Proc Nutr Soc, 2015. PMID 25490986

2015 / Narrative review

A review suggests 25(OH)D levels of ≥75 nmol/l may be needed for non-skeletal effects in Crohn's disease, but further research is needed.

This review examined the potential roles and optimal levels of vitamin D in patients with Crohn's disease. Multiple factors contribute to vitamin D deficiency in this population, including inadequate dietary intake and sunlight, impaired conversion, increased catabolism or excretion, and genetic variants. Emerging evidence suggests vitamin D may play roles in immunity, reducing disease severity, preventing hospitalizations or surgery, and preventing colon cancer. The literature suggests serum 25(OH)D concentrations of ≥75 nmol/l may be required for non-skeletal outcomes, though further research is required.

Raftery T, O'Sullivan M Proc Nutr Soc, 2015. PMID 25497215

2015 / Narrative review

Dietary factors including fiber, calcium, red meat, and processed meat are linked to colorectal cancer risk.

Extensive epidemiologic and experimental studies highlight the role of diet in colorectal cancer risk. Calcium, fiber, milk, and whole grains have been associated with a lower risk, whereas red and processed meats have been linked to an increased risk. Evidence also supports potential chemopreventive effects of vitamin D, folate, fruits, and vegetables, with mechanisms likely involving inflammation, immune response, obesity, and the gut microbiota.

Shows an association, not proof of cause and effect.

Song M, Garrett WS, Chan AT Gastroenterology, 2015. PMID 25575572

2015 / Narrative review

Short-term microbiome interventions may only have transient effects in inflammatory bowel disease as the adult microbiome tends to revert post-treatment.

Inflammatory bowel disease encompasses chronic conditions driven by excessive gastrointestinal inflammation, with the gut microbiome playing a critical role in its pathogenesis. This review examined therapies aimed at manipulating the microbiome, including diet, pre- and probiotics, antibiotics, and fecal microbiota transplant. Current literature indicates that the adult microbiome is highly resilient to short-term interventions, triggering rapid changes that typically revert to pre-treatment states once therapy concludes. Consequently, short-term manipulation of the human microbiome may produce only transient therapeutic effects.

Berg D, Clemente JC, Colombel JF Expert Rev Gastroenterol Hepatol, 2015. PMID 25665875

2015 / Narrative review

Dietary components may reduce Helicobacter pylori colonization levels and virulence without complete eradication.

This review examines dietary components used to treat and/or prevent Helicobacter pylori infection, focusing on work from the prior decade with mechanism-based plausibility and clinical results. Evidence indicates diet-based treatments may reduce H pylori colonization levels or virulence without completely eradicating the organism. Highlighted categories include bee products, probiotics, dairy products, vegetables, fruits, oils, essential oils, and herbs, spices, and other plants. The authors state that the available preclinical evidence must be followed up with rationally designed, unambiguous human trials.

Fahey JW, Stephenson KK, Wallace AJ Nutr Res, 2015. PMID 25799054

2015 / Commentary / narrative review

A commentary discusses findings that non-caloric artificial sweeteners may induce glucose intolerance by altering the gut microbiome.

Non-caloric artificial sweeteners (NAS) are widely consumed to combat weight gain and diabetes, but their role in promoting metabolic derangements remains controversial. The authors recently demonstrated that NAS consumption can induce glucose intolerance in mice and distinct human subsets through functional alterations of the gut microbiome. This commentary reviews these findings alongside other works and outlines the challenges in understanding how NAS impacts human health.

Suez J, Korem T, Zilberman-Schapira G, et al. Gut Microbes, 2015. PMID 25831243

2015 / Review

Dietary modification focusing on specific nutrients, foods, and gut microbiota impacts may aid in preventing and managing atherosclerosis.

This narrative review examines the role of diet in the prevention and complementary clinical management of atherosclerosis. It discusses evidence and mechanisms for specific nutrients and foods, including fiber, plant sterols/stanols, niacin, taurine, olive oil, omega-3 fatty acids, antioxidants, minerals, methyl nutrients, and soy. It also highlights that intestinal microbiota dysbiosis associated with certain animal food sources can generate metabolites involved in atherosclerosis development.

Torres N, Guevara-Cruz M, Velázquez-Villegas LA, et al. Arch Med Res, 2015. PMID 26031780

2015 / Narrative review

A review indicates individuals with autism show significant intestinal microbiome differences, including increased clostridial species, compared to controls.

This review examined published literature evaluating the intestinal microbiota in individuals with autism. Studies reported significant differences in the microbiome of patients with autism compared with unaffected controls, including several reports of increased clostridial species. Alterations in the microbiome, potentially influenced by environmental factors, may contribute to autism via altered immune function and bacterial metabolites, and proposed interventions to modify microbial imbalances were discussed.

Shows an association, not proof of cause and effect.

Buie T Clin Ther, 2015. PMID 26046240

2015 / Narrative review

Evidence suggests non-nutritive sweeteners have metabolic effects and may promote metabolic dysregulation through multiple mechanisms.

This review summarizes scientific evidence regarding potential mechanisms by which non-nutritive sweeteners (NNSs) might promote metabolic dysregulation. Epidemiological studies link NNS consumption, primarily from diet sodas, with increased risk for obesity, metabolic syndrome, and type 2 diabetes. Proposed mechanisms include interference with learned responses controlling glucose and energy homeostasis, disruption of gut microbiota inducing glucose intolerance, and interaction with sweet-taste receptors in the digestive tract. Laboratory findings also demonstrate an association between individual taste sensitivity to sucralose and acute metabolic responses to an oral glucose load.

Shows an association, not proof of cause and effect.

Pepino MY Physiol Behav, 2015. PMID 26095119

2015 / Narrative review

A review discusses diet, gut microbiota-derived TMAO, and cardiovascular concerns in nondialysis chronic kidney disease patients.

This narrative review examines dietary factors, gut microbiota, and the uremic toxin trimethylamine N-oxide (TMAO) in patients with nondialysis chronic kidney disease (CKD). Low-protein diets are recommended in this population because excess protein can harm kidney function and generate uremic toxins. TMAO, a degradation product of choline and L-carnitine derived primarily from animal protein such as red meat and eggs, is considered a proatherogenic metabolite with potential cardiovascular implications in CKD.

Moraes C, Fouque D, Amaral AC, et al. J Ren Nutr, 2015. PMID 26235933

2015 / Narrative review and metagenomic database analysis

Gut microbiota trimethylamine (TMA) production potential was associated with symptomatic atherosclerosis in public metagenomic data sets.

The authors reviewed literature on gut microbiota-derived trimethylamine (TMA), a metabolite linked to atherosclerosis development, to demonstrate big data integration workflows. By translating elucidated microbial pathways for TMA production into genomic orthologs, public (meta-)genomic databases were mined and linked to metadata. Reviewing pathway abundance showed that TMA production potential is associated with symptomatic atherosclerosis and facilitated identification of previously uncharacterized TMA-producing bacteria.

Shows an association, not proof of cause and effect.

Falony G, Vieira-Silva S, Raes J Annu Rev Microbiol, 2015. PMID 26274026

2015 / Historical narrative review

A review outlines how genetics, processing, and microbiota helped humans overcome lactose intolerance and notes food labeling might help manage intake.

This review analyzes the expansion of the modern dairy industry alongside the drawback of widespread lactose intolerance. Over centuries, humans overcame limitations through genetic mutations in specific populations, development of low-lactose products like cheese and yogurt, and colon microbiome adaptation. Because some modern dairy products and non-dairy items contain lactose, the authors conclude that it might be important and helpful to label foods containing lactose so individuals can control intake within the physiological limitation of ~12 g per single meal.

Silanikove N, Leitner G, Merin U Nutrients, 2015. PMID 26404364